Reading view
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the latter part of the year.
Janus Henderson chief criticises βvery aggressiveβ action by hedge fund Saba
Ali Dibadj warns against βcomplacencyβ as US group tries to take over the management of seven UK investment trusts
The 10 things likely to be more expensive in coming months despite surprise fall in inflation
The rate of inflation may have eased slightly but it is clear that UK households are facing a surge of rising costs ahead.
Firefly Aerospace kicks off first moon mission after SpaceX launch
The lander of Texas-based rocket and spacecraft builder Firefly Aerospace has begun a 45-day trip to the moon.
Stocks and bonds rally after US price pressures ease
Headline inflation rises to 2.9% in December but closely watched core figure dips unexpectedly
Climate fund hails βnew eraβ with $500mn bond deal
CIF overcomes concerns about climate finance outlook with first bond issuance
BlackRock reports record revenues as push into private markets fuels growth hopes
Annual revenues pass $20bn for first time, beating analystsβ expectations